(2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane

We are (2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane CAS:128018-44-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane
CAS.NO:128018-44-0
Synonyms:(2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane
[(1S)-1-(2S)-oxiranyl-2-phenylethyl]-carbaMic acid phenylMethyl ester
(1S,1'S)-1-(1'-N-benzyloxycarbonylamino-2'-phenyl)ethyloxirane
[S-(R*,R*)]-(1-oxiranyl-2-phenylethyl) carbamic acid phenylmethyl ester
(2S,3S)-1,2-Epoxy-3-(benzyloxycarbonyl-amino)-4-phenylbutane
 
Physical and Chemical Properties:
Density 1.205 g/cm3
Boiling Point 481.8ºC at 760 mmHg
Molecular Formula C18H19NO3
Molecular Weight 297.34800
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Saquinavir(CAS:127779-20-8).

(2S,3S)-1,2-Epoxy-3-(Cbz-amino)-4-phenylbutane


Related News: Active pharmaceutical ingredients directly impact disease.1-(sulfamoylamino)propane The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.2-(2,5-Diaminophenyl)ethanol sulfate CAS:93841-25-9 Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.131-56-6 Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.

Related Products
Product Name
4-Bromo-2-fluorobenzaldehyde View Details
2-Chloro-5-nitrobenzenesulfonic acid View Details
ethyl 4-methoxy-3-oxobutanoate View Details
(Z)-2-(2-Aminothiazol-4-yl)-2-(tert-butoxycarbonylmethoxyimino)acetic acid manufacturer B-(10-[1,1′-Biphenyl]-3-yl-9-anthracenyl)boronic acid manufacturer 3-Acetyl-2,5-dichlorothiophene manufacturer 2-Fluoro-5-nitrotoluene manufacturer 2-Bromo-4-fluoronitrobenzene manufacturer